Ametek

AMETEK’s growth model emphasizes operational excellence, organic innovation and disciplined bolt‑ons.

From 2023 to 2025 it executed multiple acquisitions: Paragon Medical and others in 2023, Virtek in 2024, Kern in January 2025, and FARO in July 2025. Integration costs temporarily diluted EMG margins in 2024 but margins recovered in 2025, consistent with the firm’s track record.

Capital returns remain balanced: an 11% dividend increase to 0.31 dollars per share quarterly and a new 1.25 billion dollar repurchase authorization. We view M&A discipline as strong, with risk centered on integration and returns on larger deals like FARO.